Self-reported health-related quality of life is an independent predictor of chemotherapy treatment benefit and toxicity in women with advanced breast cancer.
about
Factors associated with grade 3 or 4 treatment-related toxicity in women with advanced or recurrent cervical cancer: an exploratory analysis of NRG Oncology/Gynecologic Oncology Group trials 179 and 204.The science of clinical practice: disease diagnosis or patient prognosis? Evidence about "what is likely to happen" should shape clinical practice.Quality of life measures as a preliminary clinical indicator in patients with primary brain tumorsQuality of life assessments in advanced breast cancer: should there be more consistency?A systematic review of the impact of pain on overall survival in patients with cancer.Pretreatment quality of life, performance status and their relation to treatment discontinuation and treatment changes in high-risk breast cancer patients receiving chemotherapy: results from the prospective randomized ADEBAR trial.A nomogram to predict survival time in women starting first-line chemotherapy for advanced breast cancer.Quality of life (QoL) in metastatic breast cancer patients with maintenance paclitaxel plus gemcitabine (PG) chemotherapy: results from phase III, multicenter, randomized trial of maintenance chemotherapy versus observation (KCSG-BR07-02).Effect of a 12-week integrative oncology intervention on gastro-intestinal concerns in patients with gynecological and breast cancer undergoing chemotherapy.The association of chemotherapy versus hormonal therapy and health outcomes among patients with hormone receptor-positive, HER2-negative metastatic breast cancer: experience from the patient perspective.EORTC QLQ-C15-PAL quality of life score as a prognostic indicator of survival in patients with far advanced cancer.Assessing health-related quality of life in patients with breast cancer: a reply to Maratia et al.When do patient reported quality of life indicators become prognostic in breast cancer?Health-related quality of life as prognostic factor for response, progression-free survival, and survival in women with metastatic breast cancer.
P2860
Q33418750-95642E27-0C87-4508-B0CA-6618E0107EF5Q35030034-AF55EC31-79C1-489C-80AC-44CFBD9761CCQ36806125-0693C47A-0FC7-4F9D-A466-BE09F9DFC356Q38016575-8BCF0ECA-7109-470C-AB53-2CCD2B2E87BDQ39132056-27442D5C-A4BC-48AC-AD5F-754B0E62919BQ39709719-0B8FBC0D-0AC2-4B27-9DAF-3BD74FBCB357Q39766776-39A449C8-153C-41B6-87BB-E31BDF26BBE7Q41701535-5C8C50B4-227E-4596-A8B8-9C1EAF59CA81Q47753233-B9DC4787-DB99-4331-BE57-B55D15A96502Q48068021-B27AA3EF-A42E-49EE-B7EC-AE2F56EFFE60Q48084672-3D23047F-F3BA-47A1-A355-B07E3D4B3FAFQ48124124-A91588E1-9A57-434C-8657-2F55612EA705Q49216159-6F170344-BCA9-419E-B4E2-7EE6AE719374Q53051521-30F04050-21E4-4F24-809A-25630EBD5BE9
P2860
Self-reported health-related quality of life is an independent predictor of chemotherapy treatment benefit and toxicity in women with advanced breast cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Self-reported health-related q ...... n with advanced breast cancer.
@ast
Self-reported health-related q ...... n with advanced breast cancer.
@en
type
label
Self-reported health-related q ...... n with advanced breast cancer.
@ast
Self-reported health-related q ...... n with advanced breast cancer.
@en
prefLabel
Self-reported health-related q ...... n with advanced breast cancer.
@ast
Self-reported health-related q ...... n with advanced breast cancer.
@en
P2093
P2860
P356
P1476
Self-reported health-related q ...... n with advanced breast cancer.
@en
P2093
A S Coates
Australian New Zealand Breast Cancer Trials Group
M R Stockler
P2860
P2888
P304
P356
10.1038/SJ.BJC.6605649
P407
P577
2010-04-13T00:00:00Z
P5875
P6179
1038714916